Andrew Heath

Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden.

XL TechGroup, Inc. invests in the biotech, ecotech and medtech sectors. It also develops and commercializes proprietary insecticide and parasiticide products including non-toxic, pesticides, and anti-parasitic compounds for use in agriculture, horticulture, functional foods, healthcare, and veterinary applications. The firm involves in commercializing new technologies to grow and harvest oil from algae, an alternative to petroleum oil. The company was founded in 1993 and is located in Melbourne, FL.

Adjuvantix Ltd. engages in the research and development of vaccines for the treatment of cancer and infectious diseases. Its initial vaccine development targets include prostate cancer, lymphoma and TB. The company's products include ADX40-TB, ADX40-prostate cancer and ADX40-lymphoma. Adjuvantix was founded by Andrew John William Heath on October 28, 1999 and is headquartered in Sheffield, the United Kingdom.

Integrated Healing Technologies LLC develops negative pressure wound therapy devices and systems. It offers PhaseOne, advanced wound care, wound bed preparation, surgical site infection and negative pressure wound therapy. The company is headquartered in

Part of SimEx, Inc., Pioneer Technology Corp. creates large-format projection technologies. The company is based in Burbank, CA. Pioneer Technology was acquired by Iwerks Entertainment, Inc., part of SimEx, Inc. from January 09, 2002 on March 05, 1997.

TAUC3 Biologics Ltd. is engaged in the biotechnology industry. The company was founded on July19, 2019 and is headquartered in London, the United Kingdom.

Part of Novacyt SAS, Novacyt UK Holdings Ltd. is a diagnostics company that develops tests that detect infections. The company is based in Eastleigh, UK. The British company was founded in 2019. The CEO is James Martin Mccarthy.